DCGI approves Intercell, Biological E JE vaccine
Biological E. and Intercell entered into a contract agreement in 2005 to develop, manufacture, commercialize, and distribute Intercell’s Japanese Encephalitis vaccine in India and the Indian subcontinent. The
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.